Tag : Multiple Sclerosis

Latest News

Commentary: What Neurologists Can Expect From COVID-19

Newsemia
A discussion with Dr Kenneth Tyler on the most likely neurologic implications of the virus, and how the field can respond to the crisis. Source...
Latest News

FDA Clears Ozanimod (Zeposia) for MS; COVID-19 Delays Launch

Newsemia
Ozanimod is the first oral, once-daily sphingosine-1-phosphate receptor modulator approved for adults with relapsing forms of multiple sclerosis. Source link...
Neurology

What Neurologists Can Expect From COVID-19

Newsemia
A discussion with Dr Kenneth Tyler on the most likely neurologic implications of the virus, and how the field can respond to the crisis. Medscape...
Pediatrics

Early Dementia Triples; Amyloid Beta & Booze; Konzo Outbreak: Global Wake-Up Call?

Newsemia
<![CDATA[]]>(MedPage Today) — Early-onset dementia and Alzheimer’s disease diagnosis rates increased threefold from 2013 to 2017 among commercially insured people ages 30 to 64, according...
Gastroenterology

Clinical trial evaluates effectiveness of spinal cord stimulation in patients with overactive bladder

Newsemia
Keck Medicine of USC urologists are launching a clinical trial to evaluate the effectiveness of spinal cord stimulation in patients with an overactive bladder due...
Latest News

New standards needed for improving the design of clinical trials for MS patients

Newsemia
How can the perspectives of patients with multiple sclerosis (MS) be given more consideration in clinical trials? This question was investigated and corresponding recommendations were...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy